CompletedNCT04845048

Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Butantan Institute
Principal Investigator
Marta H Lopes, MD
University of Sao Paulo
Intervention
Adsorbed COVID-19 (Inactivated) Vaccine(biological)
Enrollment
2549 target
Eligibility
18 years · All sexes
Timeline
20212023

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04845048 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials